1. Home
  2. SNGX vs AMBO Comparison

SNGX vs AMBO Comparison

Compare SNGX & AMBO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Soligenix Inc.

SNGX

Soligenix Inc.

HOLD

Current Price

$1.69

Market Cap

13.8M

Sector

Health Care

ML Signal

HOLD

Logo Ambow Education Holding Ltd.

AMBO

Ambow Education Holding Ltd.

HOLD

Current Price

$3.92

Market Cap

11.9M

Sector

Real Estate

ML Signal

HOLD

Company Overview

Basic Information
Metric
SNGX
AMBO
Founded
1987
2000
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Other Consumer Services
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
13.8M
11.9M
IPO Year
1987
2010

Fundamental Metrics

Financial Performance
Metric
SNGX
AMBO
Price
$1.69
$3.92
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$6.00
N/A
AVG Volume (30 Days)
304.6K
17.5K
Earning Date
11-07-2025
08-05-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.69
Revenue
N/A
$9,699,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$5.52
Revenue Growth
N/A
23.73
52 Week Low
$1.09
$1.32
52 Week High
$6.23
$6.75

Technical Indicators

Market Signals
Indicator
SNGX
AMBO
Relative Strength Index (RSI) 59.15 42.51
Support Level $1.55 $3.78
Resistance Level $1.60 $4.37
Average True Range (ATR) 0.12 0.59
MACD 0.03 -0.07
Stochastic Oscillator 86.96 6.24

Price Performance

Historical Comparison
SNGX
AMBO

About SNGX Soligenix Inc.

Soligenix Inc is a late-stage biopharmaceutical company based in the United States. It focuses on developing and commercializing products to treat rare diseases where there is an unmet medical need. The company operates through two business segments namely Specialized BioTherapeutics and Public Health Solutions. It generates maximum revenue from Public Health Solutions with active development programs for RiVax, its ricin toxin vaccine candidate, SGX943, its therapeutic candidate for antibiotic resistant and emerging infectious disease, and its research programs to identify and develop novel vaccine candidates targeting viral infection including Ebola, Marburg and SARS-CoV-2 (the cause of COVID-19).

About AMBO Ambow Education Holding Ltd.

Ambow Education Holding Ltd is an AI-driven technology educational company. Along with its subsidiaries, the company is developing a new HybriU AI Digital Education Solution that transforms the educational environment, bridging the gap between traditional methods and the future of digital learning. The solution combines sophisticated software and hardware to create an AI-powered digital and hybrid classroom, designed to enhance educational delivery and engagement. In addition, the group offers high-quality, individualized, and dynamic career education services and products through the operation of its for-profit colleges. Substantially the majority of the group's revenues are derived from the United States, based on the geographical locations where services are provided to customers.

Share on Social Networks: